Tatsuya Suzuki Selected Research

Immunoglobulin G (IgG)

7/2013	Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease following renal transplantation.
2/2011	Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuya Suzuki Research Topics

Disease

25	Neoplasms (Cancer) 11/2023 - 01/2005
16	Type 2 Diabetes Mellitus (MODY) 03/2020 - 02/2002
11	Infections 01/2023 - 01/2002
8	Disease Progression 01/2023 - 07/2012
7	Lymphoma (Lymphomas) 01/2022 - 01/2015
6	COVID-19 01/2023 - 12/2020
6	Diabetes Mellitus 04/2015 - 08/2002
6	Hypercholesterolemia 01/2013 - 10/2006
5	Sepsis (Septicemia) 04/2023 - 01/2016
5	Critical Illness (Critically Ill) 01/2023 - 01/2017
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 08/2010
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2015 - 08/2010
4	Thrombocytopenia (Thrombopenia) 03/2024 - 12/2013
4	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2005
4	Body Weight (Weight, Body) 01/2021 - 02/2007
4	Hematologic Neoplasms (Hematological Malignancy) 12/2020 - 10/2006
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2019 - 10/2006
4	Multiple Myeloma 10/2019 - 07/2013
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2018 - 05/2013
4	Hodgkin Disease (Hodgkin's Disease) 09/2016 - 10/2012
3	Crohn Disease (Crohn's Disease) 03/2024 - 06/2010
3	Neuroblastoma 05/2023 - 08/2022
3	Pneumonia (Pneumonitis) 01/2023 - 01/2016
3	Varicose Veins (Varicose Vein) 07/2022 - 12/2018
3	Hepatitis B 04/2022 - 01/2002
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2005
3	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 08/2010
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2021 - 03/2003
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 04/2008
3	Ascites 01/2021 - 12/2004
3	Plasmacytoma 10/2019 - 01/2015
3	Biliary Atresia 12/2018 - 08/2010
3	Colitis 12/2017 - 06/2010
3	Insulin Resistance 05/2016 - 06/2007
3	Hyperglycemia 06/2014 - 08/2012
3	Glucose Intolerance 11/2012 - 09/2010
3	Dementia (Dementias) 01/2011 - 12/2005
2	Carcinoma (Carcinomatosis) 03/2024 - 01/2005
2	Splenomegaly 03/2024 - 11/2021
2	Inflammation (Inflammations) 01/2023 - 04/2022
2	Cytokine Release Syndrome 01/2023 - 01/2023
2	Thrombosis (Thrombus) 01/2023 - 01/2021
2	ST Elevation Myocardial Infarction 01/2022 - 01/2021
2	Metabolic Diseases (Metabolic Disease) 11/2021 - 02/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 02/2013
2	Fever (Fevers) 12/2020 - 06/2013
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 12/2017
2	Diarrhea 11/2019 - 01/2017
2	Ileus 09/2019 - 01/2011
2	Maple Syrup Urine Disease 08/2016 - 08/2016

Drug/Important Bio-Agent (IBA)

11	Rituximab (Mabthera)FDA Link 01/2022 - 04/2008
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2008
10	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 10/2007
7	colestimideIBA 01/2013 - 10/2006
6	Blood Glucose (Blood Sugar)IBA 01/2012 - 10/2006
5	1,5-anhydroglucitolIBA 03/2020 - 02/2013
5	Hexosaminidases (Hexosaminidase)IBA 04/2015 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2021
4	Vancomycin FDA LinkGeneric 01/2023 - 01/2017
4	AntibodiesIBA 04/2022 - 01/2002
4	Monoclonal AntibodiesIBA 04/2022 - 08/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 08/2010
3	Meropenem (Merrem)FDA LinkGeneric 01/2023 - 01/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 03/2017
3	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 03/2017
3	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 03/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2017
3	Brentuximab VedotinIBA 12/2019 - 07/2014
3	Anaplastic Lymphoma KinaseIBA 12/2019 - 10/2006
3	Epstein-Barr virus encoded RNA 1IBA 07/2019 - 01/2015
3	CreatinineIBA 04/2015 - 01/2014
3	Insulin (Novolin)FDA Link 01/2014 - 01/2012
3	NucleophosminIBA 12/2008 - 10/2005
2	EnzymesIBA 03/2024 - 11/2021
2	polyphyllin DIBA 05/2023 - 08/2022
2	CytokinesIBA 01/2023 - 01/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2005
2	Phosphotransferases (Kinase)IBA 01/2023 - 02/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021 - 12/2018
2	Vasopressins (Vasopressin)IBA 01/2021 - 08/2016
2	Cystatin CIBA 01/2021 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 12/2020 - 03/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2020 - 09/2019
2	AlbuminsIBA 03/2020 - 12/2005
2	ibrutinibIBA 08/2018 - 01/2016
2	Agammaglobulinaemia Tyrosine KinaseIBA 08/2018 - 01/2016

Therapy/Procedure

20	Therapeutics 01/2023 - 11/2005
13	Drug Therapy (Chemotherapy) 03/2024 - 10/2005
8	Liver Transplantation 11/2021 - 01/2002
5	Glycemic Control 06/2014 - 01/2012
4	Hemodiafiltration 04/2023 - 01/2017
4	Genomic Medicine 11/2022 - 09/2018
4	Oral Administration 01/2022 - 05/2016
4	Stem Cell Transplantation 12/2019 - 08/2013
3	Transplantation 11/2018 - 07/2013
2	Sternotomy 04/2024 - 03/2021
2	Laser Therapy (Surgery, Laser) 01/2022 - 01/2021
2	Excimer Lasers 01/2022 - 01/2021